Rat And Mouse Model Market Size Worth $2.9 Billion By 2028: Grand View Research, Inc.

SAN FRANCISCO, Dec. 8, 2021 /PRNewswire/ -- The global rat and mouse model market size is anticipated to reach USD 2.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.5% from 2021 to 2028. Recent advancements in the field of genetic engineering including piggyBac technologies, Cas-CLOVER, and CRISPR/Cas9 facilitate researchers to develop immunodeficient rat models which can be used for human cell/tissue regeneration and transplants.

Key Insights & Findings from the report:

• The outbred model system generated the largest revenue amongst model type as outbred strains are genetically diverse and feature well-characterized, stable genetic variation which accurately reflects the genetic structure of human populations
• Therefore, outbred strains such as the Diversity Outbred (DO) mice are used to analyze the genetic complexity behind cancer, autoimmune disorders, addiction, obesity, heart disease, diabetes, and Alzheimer's disease
• The CRISPR/Cas9 segment is anticipated to witness the fastest CAGR from 2021 to 2028 as CRISPR/Cas9 can target any definite exons for exclusion or inclusion within an mRNA
• Additionally, the use of the CRISPR/Cas9 system to generate the knockout mouse models simplifies the whole process and reduces the timeframe from 1-2 years to 6 months
• The cryopreservation segment is expected to gain significant traction during the forecast period
• The technique provides a fast and reliable procedure for archiving sperm and embryos of valuable mice strains
• Cancer is the largest revenue-generating application segment as the mouse and human genomes are homologous. Thus, it provides a good tool for cancer research as well as for drug discovery
• Pharmaceutical and biotechnology companies dominated the end-use segment in terms of revenue share in 2020. Rat and mice models are some of the most used animal models in drug discovery
• Techniques such as CRISPR/Cas9, homologous recombination, and random transgenesis help the biotech and pharma companies to analyze hypotheses or to generate rat models for human diseases
• Genetically engineered models play a vital role to assess and characterize target identification, disease pathology, and in vivo assessment of new molecular entities
• Profitable opportunities offered by the developing nations and have attracted investments from global companies in the Asia Pacific region
• For instance, in July 2021, ERS Genomics Limited signed a non-exclusive license agreement with Japan SLC. This provided the latter access to CRISPR/Cas9 patent portfolio offered by ERS Genomics
• As Japan SLC offers transgenic, hybrid, congenic, immunodeficient, inbred, and outbred animal models to research organizations; an addition of CRISPR/Cas9 technology will enhance its portfolio for rat and mouse models in Japan

Read 116 page market research report, "Rat And Mouse Model Market Size, Share & Trends Analysis Report By Type (Knockout, Knock-in), By Technology, By Service (Breeding, Rederivation), By Application (COVID-19, CVS), By End-use, And Segment Forecasts, 2021 - 2028", by Grand View Research

Key companies have leveraged advanced technologies such as machine learning, big data analytics, genome engineering tools, and next-generation sequencing technology to develop mouse and rat models with more human-like microbiomes, immune systems, and genetic backgrounds. For instance, models from the Jackson Laboratory reflect the genetic diversity showcased by the human population.

Market participants are focused to develop novel methods to certify that in vivo and in vitro testing complement each other. In this regard, an increase in the adoption rate of organoid systems has been observed. These systems guide engineering as well as enhance the use and selection of animal models. Moreover, the rise in utilization of mouse model in the analysis of SARS-CoV-2 infection in upper and lower respiratory tract infections drives the global market.

Grand View Research has segmented the global rat and mouse model market based on type, technology, service, application, end-use, and region:

• Rat And Mouse Model Type Outlook (Revenue, USD Million, 2018 - 2028)
• Knockout
• Knock-in
• Outbred
• Inbred
• Others
• Rat And Mouse Model Technology Outlook (Revenue, USD Million, 2018 - 2028)
• Nuclear transferase
• Microinjection
• Embryonic stem cells
• CRISPR/Cas9
• Other Technologies
• Rat And Mouse Model Service Outlook (Revenue, USD Million, 2018 - 2028)
• Cryopreservation
• Breeding
• Rederivation
• Genetic testing
• Quarantine depending
• Others
• Rat And Mouse Model Application Outlook (Revenue, USD Million, 2018 - 2028)
• Cardiovascular diseases
• Genetic diseases
• Cancer
• Infectious diseases
• COVID-19
• Others
• Transplantation
• Toxicology studies
• Others
• Rat And Mouse Model End-use Outlook (Revenue, USD Million, 2018 - 2028)
• Pharmaceutical & biotechnology companies
• Academic and research facilities
• Contract research & manufacturing organizations
• Rat And Mouse Model Regional Outlook (Revenue, USD Million, 2018 - 2028)
• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Asia Pacific
• China
• Japan
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa
• Saudi Arabia

List of Key Players of Rat And Mouse Model Market

• Charles River Laboratories International, Inc.
• The Jackson Laboratory
• Laboratory Corporation of America Holdings (Covance)
• Perkin Elmer (Horizon Discovery Group plc)
• genOway
• Envigo
• JANVIER LABS
• Taconic Biosciences, Inc.
• Biomedical Research Models (Biomere)
• Transpogen Biopharmaceutical, Inc.

Browse through Grand View Research's coverage of the Global Biotechnology Industry:

• Drug Testing Market – The global drug testing market size is expected to reach USD 11.7 billion by 2028. It is expected to expand at a CAGR of 4.9% from 2021 to 2028.
• Drug Discovery Informatics Market – The global drug discovery informatics market size is expected to reach USD 5.63 billion by 2028. It is expected to grow at a CAGR of 11.3% from 2021 to 2028.
• Bioinformatics Market – The global bioinformatics market is expected to reach USD 13.47 billion by 2020. Growing clinical development of biopharmaceutical and increasing need for three-dimensional drug designing technology are expected to drive the market growth.

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com 
Web: https://www.grandviewresearch.com 
Follow Us: LinkedIn | Twitter 

Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg